Business Context and Reporting Period
Company: LeMaitre Vascular, Inc. (LMAT)
Filing Type: Form 8-K (Current Report)
Date of Report: October 31, 2024
Reporting Period: Preliminary results for the quarter ended September 30, 2024.
This filing serves to notify the SEC of a press release issued on October 31, 2024, containing preliminary financial and operational results. The information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The report contains forward-looking statements based on management's current, preliminary expectations.
- Risks and Uncertainties: Actual results may differ due to risks detailed in the "Risk Factors" section of the Company's most recent Form 10-K and subsequent filings.
- Disclaimer: The Company undertakes no obligation to update forward-looking statements to reflect new information or unanticipated events.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific preliminary revenue and earnings figures for the quarter ended September 30, 2024.
- Verify the "Risk Factors" in the most recent Form 10-K to understand potential variances in forward-looking statements.
- Confirm the status of the preliminary results once the official audited or reviewed financial statements are released.